Roles of transforming growth factor-β1 in cancer stem cells

Abstract

MA Yu-Lei, LI Hai-Yuan, ZHOU Chuan, ZHOU Feng-Hai, 吕Hai-Di , WANG Shi-Guang. Roles of transforming growth factor-β1 in cancer stem cells[J]. Journal of International Oncology, 2014, 41(12): 893-895.

［1］ BarcellosHoff MH, Akhurst RJ. Transforming growth factorbeta in breast cancer: too much, too late［J］. Breast Cancer Res, 2009, 11(1): 202. ［2］ Watabe T, Miyazono K. Roles of TGFβ family signaling in stem cell renewal and differentiation［J］. Cell Res, 2009, 19(1): 103115. ［3］ He XC, Zhang J, Tong W, et al. BMP signaling inhibits intestinal stem cell selfrenewal through suppression of Wntβcatenin signaling［J］. Nat Genet, 2004, 36(10): 11171121. ［4］ Kobielak K, Stokes N, de la Cruz J, et al. Loss of a quiescent niche but not follicle stem cells in the absence of bone morphogenetic protein signaling［J］. Proc Nat Acad Sci USA, 2007, 104(24): 1006310068. ［5］ Jian H, Shen X, Liu L, et al. Smad3dependent nuclear translocation of betacatenin is required for TGFbeta1induced proliferation of bone marrowderived adult human mesenchymal stem cell［J］. Genes Dev, 2006, 20(6): 666674. ［6］ Falk S, Wurdak H, Ittner LM, et al. Brain areaspecific effect of TGFβ signaling on Wntdependent neural stem cell expansion［J］. Cell Stem Cell, 2008, 2(5): 472483. ［7］ AlHajj M, Wicha MS, BenitoHernandez A, et al. Prospective identification of tumorigenic breast cancer cells［J］. Proc Nat Acad Sci, 2003, 100(7): 39833988. ［8］ Marx J. Mutant stem cells may seed cancer［J］. Science, 2003, 301(5638): 13081310. ［9］ Rasheed ZA, Kowalski J, Smith BD, et al. Concise review: emerging concepts in clinical targeting of cancer stem cells［J］. Stem Cells, 2011, 29(6): 883887. ［10］ Dalerba P, Cho RW, Clarke MF. Cancer stem cells: models and concepts［J］. Annu Rev Med, 2007, 58: 267284. ［11］ Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cellsperspectives on current status and future directions: AACR Workshop on cancer stem cells［J］. Cancer Res, 2006, 66(19): 93399344. ［12］ Rubio D, GarciaCastro J, Martín MC, et al. Spontaneous human adult stem cell transformation［J］. Cancer Res, 2005, 65(8): 30353039. ［13］ Cozzio A, Passegué E, Ayton PM, et al. Similar MLLassociated leukemias arising from selfrenewing stem cells and shortlived myeloid progenitors［J］. Genes Dev, 2003, 17(24): 30293035. ［14］ Taylor MA, Lee YH, Schiemann WP, et al. Role of TGFβ and the tumor microenvironment during mammary tumorigenesis［J］. Gene Expr, 2011, 15(3): 117132. ［15］ Qiu LX, Yao L, Mao C, et al. TGFβ1 L10p polymorphism is associated with breast cancer susceptibility: evidence from a metaanalysis involving 47817 subjects［J］. Breast Cancer Res Treat, 2010, 123(2): 563567. ［16］ Asiedu MK, Ingle JN, Behrens MD, et al. TGF beta/TNF(alpha)mediated epithelialmesenchymal transition generates breast cancer stem cells with a claudinlow phenotype［J］. Cancer Res, 2011, 71(13): 47074719. ［17］沈娜. TGFβ1对乳腺癌细胞及乳腺癌干细胞特征作用的研究［D］. 武汉：华中科技大学, 2012. ［18］ Coyle B, Freathy C, Gant TW, et al. characterization of the transforming growth factorbeta1 induced apoptotic transcriptome in FaO hepatoma cell［J］. Biol Chem, 2003, 278(8): 59205928. ［19］ Song BC, Chung YH, Kim JA, et al. Transforming growth factorβ1 as a useful serologic marker of small hepatocellular carcinoma［J］. Cancer, 2002, 94(1): 175180. ［20］史壹雄. 转化生长因子β1诱导胰腺癌肿瘤干细胞产生的研究［D］. 杭州：浙江大学, 2011. ［21］高全立, 汪萍, Kvalheim G, 等. TGFβ1对肺癌干细胞和非干细胞增殖的影响［J］. 中国肿瘤生物治疗杂志, 2010, 17(4): 24162421. ［22］ You H, Ding W, Rountree CB. Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factorbeta［J］. Hepatology, 2010, 51(5): 16351644. ［23］刘兰兰, 杨兆娟, 邹飞雁, 等. 转化生长因子β1对肝癌细胞干性表型的调节作用［J］. 肿瘤, 2012, 32(4): 227233. ［24］ Peuelas S, Anido J, PrietoSánchez RM, et al. TGFβ increases gliomainitiating cell selfrenewal through the induction of LIF in human glioblastoma［J］. Cancer Cell, 2009, 15(4): 315327. ［25］曹响元, 赵耀东, 楼美清. TGFβ信号通路与胶质细胞瘤生物学行为的关系［J］. 中国神经肿瘤杂志, 2013, 10(1): 5157. ［26］ Anido J, SaezBorderias A, GonzalezJunca A, et al. TGFβ receptor inhibitors target the CD44(high) gliomainitiating cell population in human gliblastoma［J］. Cancer Cell, 2010, 18(6): 655668. ［27］ Qiu B, Zhang D, Wang C, et al. IL10 and TGFβ2 are overexpressed in tumor spheres cultured from human gliomas［J］. Mol Bio Rep, 2011, 38(5): 35853591. ［28］ Ikushima H, Todo T, Ino Y, et al. Autocrine TGFβ signaling maintains tumorigenicity of gliomainitiating cells through Sryrelated HMGbox factors［J］. Cell Stem Cell, 2009, 5(5): 504514. ［29］张志发. 人胆囊癌SP细胞的分选、鉴定及TGFβ对其丰度的影响和机制的研究［D］. 武汉: 华中科技大学, 2011.

[1]	Wei Yongjian, Hu Jinjing, Li Xun.Relationship between CDCA8 and tumor progression as well as that between CDCA8 and stemness maintenance of stem cells[J]. Journal of International Oncology, 2021, 48(4): 216-219.
[2]	Kang Ye, Li Jianyi, Yang Xianghong.Research progress of cancer stem cells in triplenegative breast cancer[J]. Journal of International Oncology, 2019, 46(6): 362-365.
[3]	XU Yao-Zong, GU Xiao, WANG Fei, DING Xue-Fei.Molecular mechanisms of castrationresistant prostate cancer progressed from prostate cancer by androgen deprivation treatment[J]. Journal of International Oncology, 2018, 45(8): 506-509.
[4]	Liu Hengyao, Zhao Guoli, Wang Fuwen, Cai Haibo, Zhang Yueying..Notch signaling pathway in lung cancer and lung cancer stem cells and its inhibitors[J]. Journal of International Oncology, 2018, 45(4): 250-252.
[5]	PENG Yong-Hua, PENG Li, LIANG Zhi-Man, ZHANG Xing-Mei.Application of aptamer in the study of cancer stem cells[J]. Journal of International Oncology, 2017, 44(8): 672-675.
[6]	Tong Yalan, Han Tao, Liu Zhongzheng, Yuan Gang, Liang Yan, Liu Zhaozhe, Xie Xiaodong, Yue Chengshan.Therapeutic resistance of breast cancer stem cells and its related signaling pathway[J]. Journal of International Oncology, 2017, 44(7): 544-546.
[7]	Guo Chongyong, Li Yongmei, Li Bocheng, Zhou Ling, Zhang Jian, Jia Zongshi.Expressions and clinical significances of aldehyde dehydrogenase 1 and transforming growth factor-β2 in triple negative breast cancer[J]. Journal of International Oncology, 2017, 44(11): 801-805.
[8]	郑佩.Wnt/β-catenin signaling pathway and cancer stem cells[J]. Journal of International Oncology, 2017, 44(11): 853-855.
[9]	GAN Ya-Ping, GUO Xiao-Hua, ZHANG Jun-Yu, XU Qing-Qing, WU Jiang, WANG Ren-Yong, QIU Min, JIANG Ru-Gang, LIU Fu-Xing, NING Zhi-Feng.Construction of colonic cancer drugresistant cell line COLO and its relationship with tumor stem cells[J]. Journal of International Oncology, 2016, 43(8): 646-650.
[10]	Liu Liguo, Yan Xuebing, Shan Zezhi, Jin Zhiming.Advances of cancer stem cell markers in colorectal cancer[J]. Journal of International Oncology, 2016, 43(6): 468-471.
[11]	Yan Bing, Lu Ying, Zhang Chunying, Li Qing, Mao Jun, Li Lianhong.Roles of Hippo-TAZ signaling pathway in breast cancer and breast cancer stem cells[J]. Journal of International Oncology, 2016, 43(10): 779-782.
[12]	Chen Shaohua, Qian Jun.Relationship between epithelial mesenchymal transition and tumor stem cells[J]. Journal of International Oncology, 2016, 43(1): 36-38.
[13]	LI Ming-Cong, WANG Zhan-Xiang.Recent advance in Pygopus[J]. Journal of International Oncology, 2015, 42(5): 364-366.
[14]	LI Bao-Guo, GUO Zhi.Molecular biomarkers related prognosis in hepatocellular carcinoma[J]. Journal of International Oncology, 2015, 42(5): 395-398.
[15]	LENG ZhengWei；Yang Gang；Li Yong；Shi-Gang.LY294002 decreases the proliferation of cancer stem cell-enriched spheroid cells from human hepatocellular carcinoma via inhibiting of PI3K-Akt signaling pathway[J]. Journal of International Oncology, 2015, 42(4): 241-244.

Roles of transforming growth factor-β1 in cancer stem cells

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments